$ARTH Arch Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arch Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arch Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Arch Therapeutics, Inc. for free.
IRS Number: 460524102
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: ARTH
Company Address: 235 WALNUT STREET, SUITE 6 FRAMINGHAM 01702
Phone number: 617-431-2313
Former name: ALMAH,INC, date of change: 2011-12-16
Market Capitalization: $92.55M
Prev close: $0.68
Average Daily Volume: 328,900
Days Low: $0.67
Year Low: $0.17
Year High: $0.94
Arch Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.25 | 340,910 | 85,228 | 340,910 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | O | 0.18 | 454,546 | 81,818 | 0 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | O | 81,818.30 | 454,546 | 37,190,171,901 | 1,376,813 | 922.3 K to 1.4 M (+49.29 %) |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.23 | 1,000,000 | 229,200 | 1,000,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.23 | 700,000 | 160,440 | 700,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.43 | 110,000 | 46,750 | 110,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 110,000 | 0 | 370,000 | 260 K to 370 K (+42.31 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.43 | 360,000 | 153,000 | 360,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Grant | A | 0.00 | 360,000 | 0 | 3,559,076 | 3.2 M to 3.6 M (+11.25 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.43 | 275,000 | 116,875 | 275,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Grant | A | 0.00 | 275,000 | 0 | 878,000 | 603 K to 878 K (+45.61 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.43 | 200,000 | 85,000 | 200,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.43 | 220,000 | 93,500 | 220,000 |